You are here

Aslan Pharma raises US$34m in fresh funding

Temasek Holdings.jpg
A man walks pass the Temasek Holdings office on Feb 16, 2015.


THE Republic's fledgling pharma ecosystem on Monday got a shot in the arm as biotech startup Aslan Pharmaceuticals announced it has raised US$34 million in Series C funding led by Accuron Technologies, a tech subsidiary of Temasek Holdings.

The proceeds, said Aslan, will...